Sign up to create alerts for Instruments,
Economic Events and content by followed authors
Free Sign Up Already have an account? Sign In
Quotes
All Instrument Types
- All Instrument Types
- Indices
- Equities
- ETFs
- Funds
- Commodities
- Currencies
- Crypto
- Bonds
- Certificates
Please try another search
💎 Reveal Undervalued Stocks Hiding in Any Market Get Started
U.S. FDA proposes to ease sexual abstinence rule for blood donors
© Reuters. FILE PHOTO: Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly
(Reuters) - The U.S. health regulator on Friday proposed new blood donation guidelines for men who have sex with men that are based on individual risk rather than across-the-board requirements, a move it said is in line with other countries and will help ensure the U.S. blood supply.
The U.S. Food and Drug Administration said the rules aim to reduce the risk of transfusion-transmitted HIV and are similar to those in the UK and Canada.
The proposed rule comes several years after the FDA reversed a 1980s guideline, which banned men who have sex with men from donating blood, but said they had to abstain from sex for at least a year before donating.
In 2020, the agency shortened the abstinence period to three months amid a pandemic-driven shortage of blood supply.
The removal of time-based deferrals also applies to women who have sex with the men who have sex with other men, the FDA said.
Under the new proposal, any prospective donor - regardless of gender or sexual orientation - other than those who report having a new sexual partner or multiple partners and having anal sex in the past three months, will be eligible to donate blood, provided all other eligibility criteria are met.
The regulator has also proposed new time limits for people taking pre-exposure prophylaxis or post-exposure prophylaxis treatments used for HIV prevention to reflect data showing that these medications may delay the detection of HIV and result in false negatives.
People taking oral medication would be deferred for three months after the most recent dose and those receiving injections by two years from the last dose.
The FDA will review public comments before finalizing the proposal.
Related Articles
Add Chart to Comment
Confirm Block
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
Report this comment
I feel that this comment is:
Comment flagged
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.